Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
Patients with early-stage extranodal natural killer/T-cell lymphoma had high response rates and favorable survival rates with radiation therapy and non-anthracycline-based chemotherapy regimens. Patients who achieved complete response had better survival than those who did not. The extranodal natural killer/T-cell lymphoma-specific prognostic models may require further optimization.
Authors
- Weili Zhao (ORCID: https://orcid.org/0000-0003-1704-4491)
- Jiayi Chen (ORCID: https://orcid.org/0000-0001-6417-290X)
- Xu Cheng (ORCID: https://orcid.org/0000-0001-5611-4689)
- Shu Cheng
- Wei-Guo Cao
- Yi-Min Han
- Gang Cai (ORCID: https://orcid.org/0000-0003-3323-1932)
- Shu-Bei Wang
- Pengpeng Xu
- Hui-Juan Zhong
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Shanghai Institute of Hematology (CN)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1016/j.adro.2024.101647
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China